Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats

Neuroscience

Volumn 88, Issue 1, 1999, Pages 193-200

  Willard, B ^a   Hauss Wegrzyniak, B ^a   Wenk, G L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Acetylcholine; Basal forebrain; Neuroinflammation; Rats

Indexed keywords

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CHOLINERGIC NERVE; COGNITIVE DEFECT; ENCEPHALITIS; FOREBRAIN; IMMUNOREACTIVITY; MALE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; RAT;

ACUTE DISEASE; ANIMALS; CEREBRAL CORTEX; CHOLINE O-ACETYLTRANSFERASE; CHRONIC DISEASE; ESCHERICHIA COLI; GALANIN; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; NEUROKININ B; NEUROPEPTIDE Y; NEUROPEPTIDES; NEUROTENSIN; PROSENCEPHALON; RATS; RATS, INBRED F344; SOMATOSTATIN; TIME FACTORS;

EID: 0344701036     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00216-4     Document Type: Article

References (42)

1. Aisen P. S., Davis K. L. Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am. J. Psychiat. 151:1994;1105-1113.
2. Berger-Sweeney J., Heckers S., Mesulam M.-M., Wiley R. G., Lappi D. A., Sharma M. Differential effects on spatial navigation of immunotoxin-induced cholinergic lesions of the medial septal area and nucleus basalis magnocellularis. J. Neurosci. 14:1994;4507-4519.
3. Bluthe R.-M., Dantzer R., Kelley K. W. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res. 573:1992;318-320.
4. Breitner J. C., Gav B. A., Welsh K. A., Plassman B. L., McDonald W. M., Helms M. J. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology. 44:1994;227-232.
5. Brosnan C. F., Battistini L., Raine C. S., Dickson D. W., Casadevall A., Lee S. C. Reactive nitrogen intermediates in human neuropathology: an overview. Devl Neurosci. 16:1994;152-161.
6. Brugg B., Dubreuil Y. L., Huber G., Wollman E. E., Delhaye-Bouchaud N., Mariani J. Inflammatory processes induce β-amyloid precursor protein changes in mouse brain. Proc. natn. Acad. Sci. U.S.A. 92:1995;3032-3035.
7. Drapier J.-C., Hibbs J. B. Jr. Differentiation of mouse macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J. Immun. 140:1988;2829-2838.
8. Finsen B. R., Jorgensen M. B., Zimmer J. Microglia MHC antigen expression after ischemic and kainic acid lesions of the adult rat hippocampus. Glia. 7:1993;41-49.
9. Flaris N. A., Densmore T. L., Molleston M. C., Hickey W. F. Characterization of microglia and macrophages in the central nervous system of rats: definition of the differential expression of molecules using standard and novel monoclonal antibodies in normal CNS and in four models of parenchymal reaction. Glia. 7:1993;34-40.
10. Foley P., Bradford H. F., Dochart M., Fillet H., Luine V. N., McEwen B., Buch G., Winblad B., Hardy J. Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer disease. J. Neurol. 235:1988;466-471.
11. Fonnum F. Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem. J. 115:1969;465-472.
12. Frederickson R. C. A., Brunden K. R. New opportunities in AD research - roles of immunoinflammatory responses and glia. Alz. Dis. Assoc. Disord. 8:1994;159-165.
13. Giulian D., Haverkamp L. J., Li J., Karshin W. L., Yu J., Tom D., Li X., Kirkpatrick J. B. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem. Int. 27:1995;119-137.
14. Goldgaber D., Harris H. W., Hla T., Maciag T., Donnelly R. J., Jacobsen J. S., Vitek M. P., Gajdusek D. C. Interleukin-1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelia cells. Proc. natn. Acad. Sci. U.S.A. 86:1989;7606-7610.
15. Hanisch U.-K., Neuhaus J., Rowe W., Van Rossum D., Möller D., Kettenmann H., Quirion R. Neurotoxic consequences of central long-term administration of interleukin-2 in rats. Neuroscience. 79:1997;799-818.
16. Kálmán J., Engelhardt J. I., Le W. D., Xie W., Kovacs I., Kása P., Appel S. H. Experimental immune-mediated damage of septal cholinergic neurons. J. Neuroimmun. 77:1997;63-77.
17. 2 in rat astrocyte cultures: modulatory effect of neuropeptides. Endocrinology. 124:1989;3125-3127.
18. Lowry O. H., Rosenbrough N. J., Farr A. L., Randall R. J. Protein measurement with folin phenol reagent. J. biol. Chem. 193:1951;265-275.
19. McGeer P. L., McGeer E. G., Suzuki J., Dolman C. E., Nagai T. Aging, Alzheimer's disease and the cholinergic system of the basal forebrain. Neurology. 34:1984;741-745.
20. McGeer P. L., Akiyama H., Itagaki S., McGeer E. G. Immune system response in Alzheimer's disease. Can. J. neurol. Sci. 16:1989;516-527.
21. Morgan B. P. (1990) Complement: Clinical Aspects and Relevance to Disease, pp. 215-225. Academic, San Diego, CA.
22. Mrak R. E., Sheng J. G., Griffin W. S. T. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Human Path. 26:1995;816-823.
23. Perry V. H., Matyszak M. K., Fearn S. Altered antigen expression of microglia in the aged rodent CNS. Glia. 7:1993;60-67.
24. Quan N., Sundar S. K., Weiss J. M. Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. J. Neuroimmun. 49:1994;125-134.
25. Radi R., Beckman J. S., Bush K. M., Freeman B. A. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. biol. Chem. 266:1991;4244-4250.
26. Relton J. K., Rothwell N. J. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29:1992;243-246.
27. Rinne J. O., Paljarvi L., Rinne K. Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease. J. neuronal Sci. 79:1987;67-76.
28. Rogers J., Cooper N., Webster S., Schultz J., McGeer P. L., Styren S. D., Civin W. H., Brachova L., Bradt B., Ward P., Lieberburg I. Complement activation by β-amyloid in Alzheimer's disease. Proc. natn. Acad. Sci. U.S.A. 89:1992;10016-10020.
29. Rogers J., Kirby L. C., Hempelman S. R., Berry D. L., McGeer P. L., Kaszniak A. W., Zalinski J., Cofield M., Mansukhani L., Wilson P., Kogan F. Clinical trials of indomethacin in Alzheimer's disease. Neurology. 43:1993;1609-1611.
30. Rothwell N. J., Luheshi G., Toulmond S. Cytokines and their receptors in the central nervous system: physiology, pharmacology and pathology. Pharmac. Ther. 69:1996;85-95.
31. Sheng J. G., Ito K., Skinner R. D., Mrak R. E., Rovnaghi C. R., Van Eldik L. J., Griffin S. T. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging. 17:1996;761-766.
32. Skaper S. D., Facci L., Leon A. Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induces neuronal degeneration via the nitridergic pathway. J. Neurochem. 64:1995;266-276.
33. Swaab D. F., Hofman M. A., Lucassen P. J., Salehi A., Uylings H. B. M. Neuronal atrophy, not cell death, is the main hallmark of Alzheimer's disease. Neurobiol. Aging. 15:1994;369-371.
34. Swierkosz T. A., Mitchell J. A., Warner T. D., Botting R. M., Vane J. R. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br. J. Pharmac. 114:1995;1335-1342.
35. Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30:1991;572-580.
36. Van Antwerp D. J., Martin S. J., Kafri T., Green D. R., Verman I. M. Suppression of TNF-α-induced apoptosis by NF-κB. Science. 274:1996;787-789.
37. Van der Zee C. E. E. M., Ross G. M., Riopelle R. J., Hagg T. Survival of cholinergic forebrain neurons in developing p75 deficient mice. Science. 274:1996;1729-1732.
38. Vogels O. J. M., Broere C. A. J., Ter Laak H. J., Ten Donkelaar H. J., Nieuwenhys R., Schulte B. P. M. Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol. Aging. 11:1990;3-13.
39. Wendenfeld J., Kahbha K., Reches A., Shohami E. Role of the central adrenergic system in the regulation of prostaglandin biosynthesis in rat brain. J. Neurochem. 58:1992;694-699.
40. Wenk G. L., Harrington C. A., Walker L. C., Tucker D. A., Rance N. E. Basal forebrain neurons and memory: a biochemical, histological and behavioral study of differential vulnerability to ibotenate and quisqualate. Behav. Neurosci. 106:1992;909-923.
41. Wenk G. L., Stoehr J. D., Quintana G., Mobley S. L., Wiley R. G. Behavioral, biochemical, histological and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. J. Neurosci. 14:1994;5986-5995.
42. Yan Q., Johnson E. M. Jr. Immunohistochemical localization and biochemical characterization of nerve growth factor receptor in adult rat brain. J. comp. Neurol. 290:1989;585-598.